A detailed history of Silicon Valley Capital Partners transactions in Novo Nordisk A S stock. As of the latest transaction made, Silicon Valley Capital Partners holds 1,540 shares of NVO stock, worth $172,387. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,540
Previous 1,536 0.26%
Holding current value
$172,387
Previous $219,000 16.44%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$119.07 - $145.42 $476 - $581
4 Added 0.26%
1,540 $183,000
Q2 2024

Oct 29, 2024

BUY
$122.71 - $146.91 $98,658 - $118,115
804 Added 109.84%
1,536 $219,000
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $33,374 - $73,231
367 Added 100.55%
732 $66,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $56,932 - $63,017
365 New
365 $59,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Silicon Valley Capital Partners Portfolio

Follow Silicon Valley Capital Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Capital Partners, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Capital Partners with notifications on news.